Study population
DISEASE, SOLID TUMORS, AUTOIMMUNE DISEASE
Patients with solid tumors with progression of their disease following standard of care were included.Key eligibility criteria verified during the screen procedures were age ≥18 years; ECOG performance status of 0, 1 or 2; normal hematological, liver and renal function tests; and no history of autoimmune disease. Treatment was administrated on an outpatient basis.